CRAFITY score is associated with overall survival in patients with hepatocellular carcinoma treated with transarterial chemoembolisation

被引:0
|
作者
Veelken, Rhea [1 ]
Olbrich, Anne [1 ]
Schindler, Aaron [1 ]
Lieb, Sabine [1 ]
Fischer, Janett [1 ]
Ebel, Sebastian [2 ]
Denecke, Timm [2 ]
Berg, Thomas [1 ]
van Boemmel, Florian [1 ]
机构
[1] Univ Hosp Leipzig, Div Hepatol, Dept Med 2, Leipzig, Germany
[2] Univ Hosp Leipzig, Dept Diagnost & Intervent Radiol, Leipzig, Germany
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-299
引用
收藏
页码:S507 / S507
页数:1
相关论文
共 50 条
  • [41] A refined prediction model for survival in hepatocellular carcinoma patients treated with transarterial chemoembolization
    Lee, Hae Lim
    Kim, Seok Hwan
    Kim, Hee Yeon
    Lee, Sung Won
    Song, Myeong Jun
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [42] Body Composition Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Parikh, Neehar D.
    Zhang, Peng
    Singal, Amit G.
    Derstine, Brian A.
    Krishnamurthy, Venkat
    Barman, Pranab
    Waljee, Akbar K.
    Su, Grace L.
    CANCER RESEARCH AND TREATMENT, 2018, 50 (02): : 530 - 537
  • [43] Analytic Morphomics Predicts Survival in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Parikh, Neehar D.
    Singal, Amit G.
    Zhang, Peng
    Krishnamurthy, Venkat
    Barman, Pranab
    Waljee, Akbar K.
    Su, Grace L.
    HEPATOLOGY, 2015, 62 : 420A - 421A
  • [44] Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib
    Arizumi, Tadaaki
    Ueshirna, Kazuomi
    Chishina, Hirokazu
    Kono, Masashi
    Takita, Mashiro
    Kitai, Satoshi
    Inoue, Tatsuo
    Yada, Norihisa
    Hagiwara, Satoru
    Minami, Yasunori
    Sakurai, Toshiharu
    Nishida, Naoshi
    Kudo, Masatoshi
    DIGESTIVE DISEASES, 2014, 32 (06) : 705 - 710
  • [45] Factors associated with the overall survival of elderly patients with hepatocellular carcinoma
    Hideki Fujii
    Yoshito Itoh
    Naoki Ohnishi
    Masafumi Sakamoto
    Tohru Ohkawara
    Yoshihiko Sawa
    Koichi Nishida
    Yasuo Ohkawara
    Kanji Yamaguchi
    Masahito Minami
    Takeshi Okanoue
    World Journal of Gastroenterology, 2012, (16) : 1926 - 1932
  • [46] Factors associated with the overall survival of elderly patients with hepatocellular carcinoma
    Fujii, Hideki
    Itoh, Yoshito
    Ohnishi, Naoki
    Sakamoto, Masafumi
    Ohkawara, Tohru
    Sawa, Yoshihiko
    Nishida, Koichi
    Ohkawara, Yasuo
    Yamaguchi, Kanji
    Minami, Masahito
    Okanoue, Takeshi
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (16) : 1926 - 1932
  • [47] A Molecular Hepatocellular Carcinoma Prognostic Score System Precisely Predicts Overall Survival of Hepatocellular Carcinoma Patients
    Jia, Jie
    Tang, Jing
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (02) : 273 - 283
  • [48] Controlling Nutritional Status (CONUT) Score is Associated with Overall Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib: A Multicenter Cohort Study
    Shimose, Shigeo
    Kawaguchi, Takumi
    Iwamoto, Hideki
    Tanaka, Masatoshi
    Miyazaki, Ken
    Ono, Miki
    Niizeki, Takashi
    Shirono, Tomotake
    Okamura, Shusuke
    Nakano, Masahito
    Suga, Hideya
    Yamaguchi, Taizo
    Yokokura, Yoshinori
    Noguchi, Kazunori
    Koga, Hironori
    Torimura, Takuji
    NUTRIENTS, 2020, 12 (04)
  • [49] Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
    Renguo Guan
    Jie Mei
    Wenping Lin
    Min Deng
    Shaohua Li
    Rongping Guo
    Hepatology International, 2023, 17 : 1279 - 1288
  • [50] The CRAFITY score: A promising prognostic predictor for patients with hepatocellular carcinoma treated with tyrosine kinase inhibitor and immunotherapy combinations
    Yang, Yi
    Ouyang, Jingzhong
    Zhou, Yanzhao
    Zhou, Jinxue
    Zhao, Hong
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 574 - 576